Gait and REM Sleep Behavior Disorder
Trial
N/A
Terminated
Dec. 22, 2021
Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD)
Trial
N/A
Completed
Dec. 21, 2021
Evaluation of Using Vibrotactile Coordinated Reset for Management of Parkinson's Disease
Trial
N/A
Terminated
Dec. 20, 2021
The Effect of Repetitive Transcranial Magnetic Stimulation on Cognitive Impairment in Parkinson's Disease (PD)
Trial
N/A
Completed
Dec. 20, 2021
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
Trial
N/A
Completed
Dec. 14, 2021
A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease
Trial
Phase 1
Withdrawn
Dec. 14, 2021
A Clinical Study Trial of Phenlarmide in China
Trial
Phase 1
Completed
Dec. 13, 2021
A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China
Trial
Phase 1
Completed
Dec. 13, 2021
Attentional Performance in Parkinson Disease
Trial
N/A
Withdrawn
Dec. 9, 2021
New Biomarkers in Parkinson's Disease
Trial
N/A
Unknown
Dec. 7, 2021
Real-PD Trial: Development of Clinical Prognostic Models for Parkinson's Disease
Trial
N/A
Completed
Dec. 5, 2021
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
Trial
N/A
Completed
Dec. 2, 2021
Efficacy of Nano-PSO in Parkinson's Disease.
Trial
N/A
Unknown
Dec. 1, 2021
Dance in Parkinson's Disease. A Greek Pilot Study
Trial
N/A
Completed
Nov. 25, 2021
Laser Shoes for Freezing in People With Parkinson's Disease
Trial
N/A
Unknown
Nov. 22, 2021
A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's Disease
Trial
Phase 4
Terminated
Nov. 22, 2021
An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease
Trial
Phase 4
Suspended
Nov. 22, 2021
Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and Fed Conditions
Trial
Phase 1
Unknown
Nov. 18, 2021
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
Trial
N/A
Completed
Nov. 16, 2021
Keppra IV for the Treatment of Motor Fluctuations in Parkinson's Disease
Trial
Phase 4
Withdrawn
Nov. 15, 2021